D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis

被引:36
作者
Cosmi, Benilde [1 ]
Legnani, Cristina [1 ]
Cini, Michela [1 ]
Favaretto, Elisabetta [1 ]
Palareti, Gualtiero [1 ]
机构
[1] St Orsola Marcello Malpighi Hosp, Dept Angiol & Blood Coagulat Marino Golinelli, I-40138 Bologna, Italy
关键词
venous; thromboembolism; vitamin K antagonists; thrombosis; hypercoagulability; thrombophilia;
D O I
10.1016/j.thromres.2007.12.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: To assess the predictive value of D-dimer (D-d) and Factor VIII (FVIII) in combination for recurrent venous thromboembolism (VTE) after vitamin K antagonist (VKA) therapy suspension. Design and methods: Consecutive outpatients with a first episode of idiopathic proximal deep vein thrombosis of the lower Limbs were enrolled on the day of VKA suspension. After 30+/-10 days, D-d (cut-off value: 500 ng/mL), chromogenic FVIII activity and inherited thrombophilia were determined. Follow-up was 2 years. Results: Overall recurrence rate was 16.4% (55/336; 95% Cl:13-21%). The multivariate hazard ratio (HR) for recurrence was 2.45 (95%Cl: 1.24-4.99) for abnormal D-d and 2.76 (95% Cl:1.57-4.85) for FVIII above the 75th percentile(2.42 U/mL) after adjustment for age, sex, thrombophilia, VKA duration and residual venous obstruction. When compared with normal D-d and FVIII, the multivariate HR was 4.5 (95% Cl: 1.7-12.2) for normal D-d with FVIII above 2.42 U/mL and 2.7 (95% Cl: 1.2-6.6) and 7.1 (95% Cl:2.8-17.6) for abnormal D-d with FVIII, respectively, below and above 2.42 U/mL. Interpretation and conclusions: D-d and FVIII at 30+/- 10 days after VKA withdrawal are independent risk factors for recurrent VTE. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:610 / 617
页数:8
相关论文
共 31 条
[1]   Extended oral anticoagulant therapy after a first episode of pulmonary embolism [J].
Agnelli, G ;
Prandoni, P ;
Becattini, C ;
Silingardi, M ;
Taliani, MR ;
Miccio, M ;
Imberti, D ;
Poggio, R ;
Ageno, W ;
Pogliani, E ;
Porro, F ;
Zonzin, P .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (01) :19-25
[2]   Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. [J].
Agnelli, G ;
Prandoni, P ;
Santamaria, MG ;
Bagatella, P ;
Iorio, A ;
Bazzan, M ;
Moia, M ;
Guazzaloca, G ;
Bertoldi, A ;
Tomasi, C ;
Scannapieco, G ;
Ageno, W ;
Ascani, A ;
Villalta, S ;
Frulla, M ;
Mosena, L ;
Girolami, A ;
Vaccarino, A ;
Alatri, A ;
Palareti, G ;
Marchesi, M ;
Ambrosio, GB ;
Parisi, R ;
Doria, S ;
Steidl, L ;
Ambrosini, F ;
Silingardi, M ;
Ghirarduzzi, A ;
Iori, I .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) :165-169
[3]   The thrombophilias: Well-defined risk factors with uncertain therapeutic implications [J].
Bauer, KA .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (05) :367-373
[4]   Antithrombotic therapy for venous thromboembolic disease [J].
Büller, HR ;
Agnelli, G ;
Hull, RD ;
Hyers, TA ;
Prins, AH ;
Raskob, GE .
CHEST, 2004, 126 (03) :401S-428S
[5]  
Cosmi B, 2005, THROMB HAEMOSTASIS, V94, P969
[6]   D-dimer levels and risk of recurrent venous thromboembolism [J].
Eichinger, S ;
Minar, E ;
Bialonczyk, C ;
Hirschl, M ;
Quehenberger, P ;
Schneider, B ;
Weltermann, A ;
Wagner, O ;
Kyrle, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (08) :1071-1074
[7]   The evaluation of suspected pulmonary embolism [J].
Fedullo, PF ;
Tapson, VF .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (13) :1247-1256
[8]   Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children [J].
Goldenberg, NA ;
Knapp-Clevenger, R ;
Manco-Johnson, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (11) :1081-1088
[9]   How we diagnose and treat deep vein thrombosis [J].
Hirsh, J ;
Lee, AYY .
BLOOD, 2002, 99 (09) :3102-3110
[10]   Duration of anticoagulant therapy after first episode of venous thrombosis in patients with inherited thrombophilia [J].
Hirsh, J ;
Kearon, C ;
Ginsberg, J .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (19) :2174-2177